CUBE vs NERV · P/E 25, rev $1.07B vs P/E 2.2, $12.4M cap
CubeSmart (CUBE) versus Minerva Neurosciences Inc (NERV) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Minerva Neurosciences Inc (NERV) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported NERV revenue for 2024-12-31 was $0. Net income was $1.4M. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
Not investment advice. Open the CUBE and NERV stock pages for the full models.
Not investment advice.